Hyclone Media

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-RML-2083261 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-06, July 12, 2021.

The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product Manufacturing, with a size standard of 1250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.

The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for:

Manufacturer: Cytiva https://www.cytivalifesciences.com/en/us

Qty 40 of catalog#SH31027.01 DPM 0.5 L Hyclone Cell Boost 7b – ADCF

Qty 50 of catalog#SH31037.02 DPM 10L Hyclone ActiPro – ADCF

Qty 20 of catalog#SH31026.01 DPM 5L Hyclone Cell Boost 7a – ADCF

Qty 20 of catalog#RR18758.01 LM CDM4HEK293 10L

Qty 3 of catalog#SH3A3770.02 DPM- CDM4HEK293 Powder, w/o L-Glutamine and NaCl, 500L

Qty 30 of catalog#SH30558.02 LM- CDM4CHO w/o LGLUT 1000 mL

Qty 4 of catalog#SH30897.02 LM- 10% Antifoam Soln Q7-2587, IRR 2.5L

Include shipping and handling on quote. 

To be delivered in four different shipments. 

Description

PN

Ship Dates and Qty/shipment

 

ASAP

1-Nov-22

3-Jan-22

1-April-22

1st ship

2nd ship

3rd ship

4th ship

0.5 L, HyClone(TM) Cell Boost(TM) 7b - ADCF

SH31027.01

10

10

10

10

DPM- 10 L, HyClone(TM) ActiPro(TM) - ADCF

SH31037.02

13

12

13

12

DPM- 5 L, HyClone(TM) Cell Boost(TM) 7a - ADCF

SH31027.04

5

5

5

5

LM - CDM4HEK293, 10L, Vaccine Research Center NIAID NIH

RR18758.01

5

5

5

5

CDM4HEK293 media (500L)

SH3A3770.02

1

0

0

0

DPM- CDM4HEK293 Powder, w/o L-Glutamine and NaCl, 500 L, CUSTOM MADE FOR NIH DIV

SH3A3770.02

1

0

0

0

LM- CDM4CHO W/O LGLUT, 1000mL

SH30558.02

8

7

8

7

LM- 10% ANTIFOAM SOLN Q7-2587, IRR, 2.5L

SH30897.02

1

1

1

1

Place of Performance: NIH, 9 West Watkins Mill Road, Gaithersburg, MD 20878, United States.  FOB: Destination

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following; technical capability to meet the requirements and price.

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (OCT 2018)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JULY 2021)

*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (DEC 2013)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)

52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than August 12, 2021 @ 1:00 EST

Offers may be e-mailed to Janna Weber (E-Mail/ janna.weber@nih.gov). Offers shall include RFQ number in the subject line (RFQ-RML-2083261). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency. 

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Janna Weber @ janna.weber@nih.gov.